Pediatric patients and drug safety

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 3, 2005, Pages 122-124

  Hirschfeld, Steven ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; VINCRISTINE;

CANCER THERAPY; CHILDHOOD CANCER; CHILDHOOD DISEASE; CLINICAL MEDICINE; CLINICAL TRIAL; CONTRACT; CUSTODY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; LAW; METHODOLOGY; PATENT; PEDIATRICS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RARE DISEASE; REGULATORY MECHANISM; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UNITED STATES;

BIOMEDICAL RESEARCH; CHILD; DRUG THERAPY; HUMANS; NEOPLASMS; PEDIATRICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 15444367842     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200503000-00002     Document Type: Editorial

References (3)

1. Best Pharmaceuticals for Children Act. Available at http://www.fda.gov/ cder/pediatric/PL107-109.pdf. Accessed February 9, 2005.
2. Pediatric Research Equity Act. Available at http://www.fda.gov/cder/ pediatric/S-650-PREA.pdf. Accessed February 9, 2005.
3. International Conference on Harmonisation Document E11: Clinical Investigation of Medicinal Products in the Pediatric Population. Available at http://www.ich.org/MediaServer.jser?@_ID=487&@_TYPE=MULTIMEDIA& @_TEMPLATE=616&@_MODE=GLB. Accessed February 9, 2005.